The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)-Global Market Insights and Sales Trends 2025
Synopsis
The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market. Blood Transfusion, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibiotic segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, driven by demand from China, the second largest economy with some signs of stabilising, the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) covered in this report include Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc and Shuttle Pharmaceuticals LLC, etc.
The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aeolus Pharmaceuticals, Inc.
Atox Bio Ltd
BCN Biosciences LLC
Cellphire Inc
Daiichi Sankyo Co Ltd
FirstString Research Inc
RxBio Inc
Shuttle Pharmaceuticals LLC
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, Segment by Type:
Blood Transfusion
Antibiotic
Others
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market. Blood Transfusion, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibiotic segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, driven by demand from China, the second largest economy with some signs of stabilising, the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) covered in this report include Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc and Shuttle Pharmaceuticals LLC, etc.
The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aeolus Pharmaceuticals, Inc.
Atox Bio Ltd
BCN Biosciences LLC
Cellphire Inc
Daiichi Sankyo Co Ltd
FirstString Research Inc
RxBio Inc
Shuttle Pharmaceuticals LLC
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, Segment by Type:
Blood Transfusion
Antibiotic
Others
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
1.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Overview
1.1.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Scope
1.1.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Status and Outlook
1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2018-2029)
1.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Region (2018-2023)
1.5 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2029)
1.6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2029)
1.6.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2029)
1.6.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2029)
1.6.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2029)
1.6.5 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2029)
2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market by Type
2.1 Introduction
2.1.1 Blood Transfusion
2.1.2 Antibiotic
2.1.3 Others
2.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2018-2023)
2.2.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Type (2018-2029)
3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2018-2023)
3.2.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Breakdown by Application (2018-2029)
4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Competition Analysis by Players
4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) as of 2022)
4.3 Date of Key Players Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
4.4 Global Top Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Headquarters and Area Served
4.5 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service
4.6 Competitive Status
4.6.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Aeolus Pharmaceuticals, Inc.
5.1.1 Aeolus Pharmaceuticals, Inc. Profile
5.1.2 Aeolus Pharmaceuticals, Inc. Main Business
5.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.1.4 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments
5.2 Atox Bio Ltd
5.2.1 Atox Bio Ltd Profile
5.2.2 Atox Bio Ltd Main Business
5.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.2.4 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.2.5 Atox Bio Ltd Recent Developments
5.3 BCN Biosciences LLC
5.3.1 BCN Biosciences LLC Profile
5.3.2 BCN Biosciences LLC Main Business
5.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.3.4 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.3.5 Cellphire Inc Recent Developments
5.4 Cellphire Inc
5.4.1 Cellphire Inc Profile
5.4.2 Cellphire Inc Main Business
5.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.4.4 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.4.5 Cellphire Inc Recent Developments
5.5 Daiichi Sankyo Co Ltd
5.5.1 Daiichi Sankyo Co Ltd Profile
5.5.2 Daiichi Sankyo Co Ltd Main Business
5.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.5.4 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.5.5 Daiichi Sankyo Co Ltd Recent Developments
5.6 FirstString Research Inc
5.6.1 FirstString Research Inc Profile
5.6.2 FirstString Research Inc Main Business
5.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.6.4 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.6.5 FirstString Research Inc Recent Developments
5.7 RxBio Inc
5.7.1 RxBio Inc Profile
5.7.2 RxBio Inc Main Business
5.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.7.4 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.7.5 RxBio Inc Recent Developments
5.8 Shuttle Pharmaceuticals LLC
5.8.1 Shuttle Pharmaceuticals LLC Profile
5.8.2 Shuttle Pharmaceuticals LLC Main Business
5.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Products, Services and Solutions
5.8.4 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million) & (2018-2023)
5.8.5 Shuttle Pharmaceuticals LLC Recent Developments
6 North America
6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics
11.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Trends
11.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
11.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
11.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
